Lab
Tennessee Valley Regional Laboratory
Tennessee Valley Regional Laboratory was paid $4K by Medicaid between Jan 2018 and Sep 2020, across 42 billing codes. Its largest line is P9603, Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled — 49% of everything it billed.
33Billing provider infoTENNESSEE VALLEY REGIONAL LABORATORY
KNOXVILLE, TN 37909
KNOXVILLE, TN 37909
33aNPI1164850293assigned 10/29/2013
33bProvider typeClinical Medical Laboratory
28Total paid$4K
24GClaims36,910
24DCodes billed42
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#60 of 70
Median peer was paid$141K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,720 | $4K | |
| 2019 | 13,317 | $0.00 | |
| 2020 | 12,873 | $2.82 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 49% | 4,142 | 2,351 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13% | 2,074 | 1,397 | $516.30 |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 8.0% | 1,010 | 448 | $313.22 |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.8% | 262 | 165 | $226.80 |
| 80053 | Comprehensive metabolic panel | 5.3% | 248 | 205 | $207.48 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.0% | 454 | 352 | $194.37 |
| 80061 | Lipid panel | 4.9% | 141 | 120 | $193.53 |
| 36415 | Collection of venous blood by venipuncture | 3.4% | 3,546 | 2,134 | $132.72 |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 779 | 594 | $102.44 |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 199 | 164 | $80.16 |
| 81000 | <1% | 578 | 427 | $27.16 | |
| 82607 | <1% | 217 | 162 | $14.14 |
30 more codes
| 82565 | <1% | 1,884 | $2.40 | |
| 84520 | <1% | 1,890 | $1.85 | |
| 82947 | 0% | 1,879 | $0.00 | |
| 85610 | 0% | 709 | $0.00 | |
| 82310 | 0% | 1,874 | $0.00 | |
| 84155 | 0% | 1,171 | $0.00 | |
| 84450 | 0% | 1,168 | $0.00 | |
| 83718 | 0% | 643 | $0.00 | |
| 82374 | 0% | 1,880 | $0.00 | |
| 82247 | 0% | 1,157 | $0.00 | |
| 84460 | 0% | 1,173 | $0.00 | |
| 84295 | 0% | 385 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 108 | $0.00 |
| 82465 | 0% | 71 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 106 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 14 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 46 | $0.00 |
| 84439 | 0% | 37 | $0.00 | |
| 87481 | 0% | 32 | $0.00 | |
| 87653 | 0% | 33 | $0.00 | |
| 84132 | 0% | 1,911 | $0.00 | |
| 84075 | 0% | 1,171 | $0.00 | |
| 84478 | 0% | 645 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 34 | $0.00 |
| 82435 | 0% | 1,880 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 51 | $0.00 |
| 82040 | 0% | 1,168 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 46 | $0.00 |
| 87640 | 0% | 48 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPURGEON, LUCY (PART OWNER)